Molecular mechanisms ntawm Abdominal aneurysms

Published Date: 02 Mar 2023

When the arteries supplying blood to the stomach and liver swell and burst, it is an emergency in which 50% of patients die before reaching the hospital. This "silent killer" situation, know...

Read Full News

Latest News



Todays Updates


Why Oxygen Stigma Persists, With Mike Hess, MPH Mike Hess, MPH


On World Oxygen Day, the COPD Foundation's Mike Hess outlines the stigma, training gaps, and Medicare barriers affecting patients on supplemental oxygen.

When to Switch Biologics in Severe Asthma, With Florence Schleich, MD, PhD Florence Schleich, MD, PhD


Schleich says biologic switching in severe asthma should follow exacerbation phenotyping and discusses response predictors and standardized follow-up.

Lower Baseline FVC Linked to Better Sarcoidosis Treatment Response Vivienne Kahlmann


A post-hoc PREDMETH analysis presented at ERS 2026 links lower baseline FVC and shorter disease duration with greater FVC gains on first-line therapy.

Vanzacaftor Regimen Lets Some Children With Cystic Fibrosis Stop PERT


Vanzacaftor Regimen Lets Some Children With Cystic Fibrosis Stop PERT

Q&A: Curcumin Lowers IL-17 in COPD, With Retno Ariza Soemarwoto, MD


Q&A: Curcumin Lowers IL-17 in COPD, With Retno Ariza Soemarwoto, MD

Real-World Data Back Stiripentol’s Effect on Seizures in Dravet Syndrome Marco Meglio


A retrospective 10-center U.S. study found stiripentol reduced convulsive seizure frequency, status epilepticus episodes, and emergency health care use in patients with Dravet syndrome.

Diazepam Nasal Spray Terminates Most Pediatric Status Epilepticus Episodes in Seizure Clusters, Post Hoc Analysis Shows Isabella Ciccone, MPH


Newly presented post hoc analyses examined diazepam nasal spray for status epilepticus in seizure clusters and intervals between clusters in children, alongside real-world data on rescue medication prescribing.

Todays Updates


Why Oxygen Stigma Persists, With Mike Hess, MPH Mike Hess, MPH


On World Oxygen Day, the COPD Foundation's Mike Hess outlines the stigma, training gaps, and Medicare barriers affecting patients on supplemental oxygen.

When to Switch Biologics in Severe Asthma, With Florence Schleich, MD, PhD Florence Schleich, MD, PhD


Schleich says biologic switching in severe asthma should follow exacerbation phenotyping and discusses response predictors and standardized follow-up.

Lower Baseline FVC Linked to Better Sarcoidosis Treatment Response Vivienne Kahlmann


A post-hoc PREDMETH analysis presented at ERS 2026 links lower baseline FVC and shorter disease duration with greater FVC gains on first-line therapy.

Vanzacaftor Regimen Lets Some Children With Cystic Fibrosis Stop PERT


Vanzacaftor Regimen Lets Some Children With Cystic Fibrosis Stop PERT

Q&A: Curcumin Lowers IL-17 in COPD, With Retno Ariza Soemarwoto, MD


Q&A: Curcumin Lowers IL-17 in COPD, With Retno Ariza Soemarwoto, MD

Real-World Data Back Stiripentol’s Effect on Seizures in Dravet Syndrome Marco Meglio


A retrospective 10-center U.S. study found stiripentol reduced convulsive seizure frequency, status epilepticus episodes, and emergency health care use in patients with Dravet syndrome.

Diazepam Nasal Spray Terminates Most Pediatric Status Epilepticus Episodes in Seizure Clusters, Post Hoc Analysis Shows Isabella Ciccone, MPH


Newly presented post hoc analyses examined diazepam nasal spray for status epilepticus in seizure clusters and intervals between clusters in children, alongside real-world data on rescue medication prescribing.

Latest News

HTTP error: 503HTTP error: 503

News All Time

HTTP error: 503HTTP error: 503 HTTP error: 503HTTP error: 503 HTTP error: 503 HTTP error: 503 HTTP error: 503 HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Approves First Menin Inhibitor for Acute Leukemia

2.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

3.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

4.

Common intracellular toxin could help fight leukemia

5.

Tumor-targeting fluorescent bacteria illuminate cancer for precision surgery


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot